The Human Body May Age in Two Major Bursts, and a New Study Reveals What Drives Them

We tend to think of aging as something that happens gradually to the entire body at once. But a new study suggests our organs and tissues may be following very different clocks, with some going through periods of rapid change years or even decades before others.

Researchers at Sanford Burnham Prebys Medical Discovery Institute analyzed aging patterns across 40 types of human tissue and uncovered several distinct trajectories. One of the most striking involved the arteries, which appeared to undergo their fastest period of structural aging while people were still in their 30s.

But that wasn’t the only surprise.

When researchers mapped how different tissues changed over time, they found that several seemingly unrelated parts of the body, including the esophagus, colon, and prostate, followed a similar two-stage aging pattern to the ovaries. That raises an intriguing question: why would tissues with such different jobs appear to age according to a similar schedule?

The findings, published in Nature Aging in August 2026, suggest that aging may be less like one clock ticking steadily forward and more like a collection of biological clocks that speed up and slow down at different points in life. Understanding when those changes happen, and what drives them, could eventually help researchers identify better windows for preventing or slowing age-related decline.

Key Findings

Applying the research team’s computational framework to 25,306 post-mortem biopsies from 40 tissues in 970 donors aged 21 to 70 years revealed that organ structural aging progresses via distinct, nonlinear temporal trajectories. Vascular tissue structural aging accelerates early; uterus and vagina structural aging accelerates late around menopause; and certain tissues, including digestive and male reproductive organs, show biphasic accelerations. The team also found that these organ-specific aging bursts share a common molecular fingerprint defined by rising inflammation and falling energy production, and that the ovaries appear to function as a systemic pacemaker whose hormonal signaling shapes aging timelines across organs unconnected to reproduction.

The Research: Building a New Window Into Tissue Age

Most aging research has focused on molecules: gene expression patterns, DNA methylation marks, protein concentrations in blood. The physical structure of tissues – how cells, blood vessels, and the surrounding matrix are actually organized – has received far less systematic attention, largely because analyzing thousands of microscopic images at scale has not been technically feasible until recently.

Sanju Sinha, PhD, assistant professor in the Cancer Molecular Therapeutics Program at Sanford Burnham Prebys, led the effort. The team found the requisite data in archives hosted by the Genotype-Tissue Expression (GTEx) Project, a major NIH Common Fund initiative to accelerate the study of tissue- and cell-specific gene expression and regulation.

PathStAR: Seeing Age in Tissue Structure

The instrument at the center of this work is a computational framework called PathStAR, which stands for Pathology-based Structural Aging Rate. The team developed PathStAR to quantify tissue structural aging from routine histopathology images without training the model to predict chronological age. That methodological choice matters: by not training on chronological age, the system had to identify structural patterns associated with biological deterioration on their own terms rather than learn to recognize what a 50-year-old’s tissue “should” look like.

PathStAR works as a deep-learning computer vision model that segments scanned histopathology slides into smaller images known as patches. Those patches are then analyzed to extract features reflecting underlying tissue structure, and PathStAR uses these features to chart how structural aging occurs over time.

Sinha described the approach: “Our goal is to understand how aging occurs at a structural level. To do this, we needed thousands of scanned images of biopsies of normal tissue over a wide range of ages.” The GTEx dataset provided exactly that, though not in the way those samples were originally intended to be used. As Sinha noted, the project had generated tens of terabytes of imaging data that had gone nearly untouched, with most researchers drawing only on the molecular data.

The Dataset: 25,000 Biopsies, 40 Tissue Types

Applying PathStAR to 25,306 postmortem biopsies spanning 40 tissue types from 970 individuals aged 21 to 70 showed that structural aging unfolds through non-linear phases rather than gradual decline. No comparable systematic mapping of structural change across the full breadth of human organ types had been produced before, largely because the imaging analysis required to do so was not computationally feasible at scale.

The team identified three distinct temporal programs: early-aging tissues, with the vascular system peaking in the 30s; late-aging tissues, with the uterus and vagina peaking around menopause; and biphasic-aging tissues – specifically digestive and male reproductive organs – which show two acceleration periods.

The Three Aging Trajectories

Early Agers: The Vascular System

Arterial aging is among the study’s most immediately actionable findings. The arteries do not wait for midlife: vascular tissue structural aging accelerates early, with the steepest period of structural change occurring during the 30s. Individuals whose arteries showed more accelerated structural aging were also more likely to carry pathological evidence of atherosclerosis – the buildup of plaque inside arterial walls that narrows them and raises the risk of heart attack and stroke.

Visible changes in arteries and early plaque formation begin in the 20s and 30s, with advanced plaque developing through those decades. The study’s structural aging data aligned with pathology records showing that early plaque formation in arteries also increased most steeply during the 30s before leveling off later.

Cardiovascular risk management likely needs to begin earlier than standard clinical guidelines currently recommend, particularly for individuals whose family history or lifestyle factors suggest elevated vascular vulnerability. Individuals in their 30s with elevated LDL cholesterol, hypertension, or a family history of early cardiovascular disease should discuss earlier imaging and monitoring with their physicians.

Late Agers: Female Reproductive Tissues

The uterus and vagina follow the opposite pattern to arteries: structural stability through early adulthood, followed by a concentrated period of change in the early and mid-50s. The structural changes observed in these tissues included features consistent with tissue atrophy and thinning of the endometrium – the inner lining of the uterus – changes directly attributable to the sharp decline in estrogen that characterizes the menopausal transition. Menopause occurs on average around age 50 to 51.

The ovaries told a more complex story. Rather than aging late alongside the rest of the female reproductive system, ovarian tissue showed two distinct periods of accelerated structural change: one around ages 35 to 40, and another around ages 55 to 60. That first burst aligns with the well-documented decline in fertility that accelerates from the mid-30s onward as oocyte quantity and quality fall. The second aligns with the postmenopausal period.

PathStAR captured this non-linear ovarian functional decline – including fertility decline in the 30s and the menopausal shift in the 50s – without any training on chronological age. Transcriptomic and methylation profiles from the identical samples did not detect the same two peaks, meaning the structural signal was visible in tissue architecture when molecular profiling of the same samples could not find it.

Biphasic Agers: The Gut, the Prostate, and the Testis

Nine of the 14 tissues with high-confidence trajectories showed what the researchers called “biphasic” aging, passing through two distinct windows of intensified structural change rather than aging continuously or declining in a single burst. For digestive and male reproductive organs, those discrete phases appear to land in the 30s and again in the 50s.

The tissues involved include the esophagus, stomach, colon, and small intestine, as well as the prostate and testis in male bodies. The fact that digestive organs and male reproductive tissues follow the same two-burst timing points toward a systemic driver rather than local tissue-level factors alone.

The Ovarian Pacemaker: How Hormones Coordinate Whole-Body Aging

Across all three aging trajectories, the apparent role of the ovaries – and the hormonal signaling they represent – stands out as a coordinating factor across tissues with no obvious reproductive connection.

As Sanju Sinha stated: “More than half the tissues we studied followed the structural aging of the ovaries, so we see the ovaries as a kind of pacemaker for whole-body aging. By developing therapies to protect reproductive aging, we see the potential to protect multiple other organs and increase overall healthspan.”

The mechanism Sinha’s research team proposes centers on estrogen and its receptors. Estrogen is not confined to the reproductive system; it circulates throughout the body and binds to receptors expressed in a wide range of tissues, including the digestive tract. During accelerated aging phases, most tissues showed increased inflammation, decreased energy generation, and reduced cell division capacity, alongside tissue-specific disruptions like impaired arterial lipid processing and diminished estrogen response in female reproductive organs.

Estrogen receptors are expressed throughout the gastrointestinal tract and are understood to play a role in maintaining the gut’s mucosal barrier. When estrogen signaling declines – as it does during both the mid-30s ovarian transition and the postmenopausal period – that mucosal maintenance is affected. The digestive system’s two-burst aging timeline tracks with those two hormonal inflection points.

PathStAR further revealed coordinated deterioration among tissues within an organ system and unexpected correlations between digestive and reproductive structural aging. Individuals who showed accelerated structural aging in the colon and esophagus also tended to show it in the prostate, a pattern of co-aging consistent with shared systemic drivers.

The Shared Molecular Signature of Aging Bursts

Across different organ types and different aging timelines, the study identified a common molecular signature that characterizes periods of accelerated structural aging: increased inflammation alongside reduced energy production, repair, and quality control.

These molecular changes do not arrive steadily. The study shows they occur in pulses, with different organs experiencing those pulses at different times. For drug developers and clinicians, that temporal precision is potentially valuable. If a colon’s structural aging accelerates most sharply in a person’s 30s, a therapeutic intervention targeting inflammation or mitochondrial function in gastrointestinal tissue during that decade would have a different risk-benefit profile than one applied at 60, after much of the structural change has already occurred.

Limitations and What the Study Cannot Yet Tell Us

The samples were all post-mortem, which introduces an inherent limitation: the circumstances of death can affect tissue condition, particularly in younger donors, and those effects may not be fully separable from biological aging signals. The study design is observational and cross-sectional rather than longitudinal, meaning it reconstructs aging trajectories from different individuals at different ages rather than following the same people over time.

The study identifies correlations between structural aging patterns and molecular states; it does not establish that the molecular changes cause the structural deterioration, nor that intervening on those pathways would alter the structural trajectory. Causal direction is not yet established.

The GTEx cohort also has demographic constraints. As with most large biobanks, representation across ethnicities, geographic regions, and socioeconomic backgrounds is uneven, which limits how broadly the findings can be generalized.

What This Means for You

The aging bursts study from Sanford Burnham Prebys represents the most systematic structural mapping of human organ aging published to date. Its findings carry practical weight for anyone thinking about preventive health across the adult lifespan.

The arterial system begins its most concentrated period of structural deterioration in the 30s, and subclinical plaque is detectable in a meaningful proportion of adults before age 30. Individuals in their 30s with elevated LDL cholesterol, hypertension, or a family history of early cardiovascular disease should discuss earlier imaging and monitoring with their physicians.

If estrogen signaling coordinates aging across the digestive system, the vasculature, and male reproductive organs in addition to the uterus and ovaries, then the timing and management of menopause – and potentially the use of hormonal therapies during and after the menopausal transition – become questions with whole-body aging consequences rather than just reproductive ones. As Sanju Sinha framed it: “Our findings can be the foundation for building a structural aging atlas to inform the design and assessment of anti-aging interventions.”

That atlas, if it reaches clinical translation, would shift the design of preventive medicine from age-based protocols to organ-specific, trajectory-aware interventions that target the periods of maximum structural vulnerability for each tissue type. The gut’s structural health in midlife may be more intimately tied to reproductive hormonal changes than gastroenterology has previously had reason to consider.

Disclaimer: This information is not intended to be a substitute for professional medical advice, diagnosis, or treatment and is for information only. Always seek the advice of your physician or another qualified health provider with any questions about your medical condition and/or current medication. Do not disregard professional medical advice or delay seeking advice or treatment because of something you have read here.

AI Disclaimer: This article was created with the assistance of AI tools and reviewed by a human editor.

Trending Products